The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

Pokaži ostale verzije (1)

Lineage fate decisions underpin much of development as well as tissue homeostasis in the adult. A mechanistic paradigm for such decisions is the erythroid versus myeloid fate decision controlled by cross-antagonism between gata1 and pu.1 transcription factors. In this study, we have systematically t...

Bibliografski detalji
Glavni autori:	Monteiro, R, Pouget, C, Patient, R
Format:	Journal article
Jezik:	English
Izdano:	2011

Slični predmeti

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ
od: Monteiro, R, i dr.
Izdano: (2011)

Lineage marker synchrony in hematopoietic genealogies refutes the PU.1/GATA1 toggle switch paradigm
od: Michael K. Strasser, i dr.
Izdano: (2018-07-01)

The Roles of TIF1γ in Cancer
od: Chengpeng Yu, i dr.
Izdano: (2019-10-01)

Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios
od: Hoppe, P, i dr.
Izdano: (2016)

Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
od: Yorihisa Kotobuki, i dr.
Izdano: (2021-01-01)

GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
od: Nerlov, C, i dr.
Izdano: (2000)

Clinical characteristics of patients with anti-TIF1-γ antibodies
od: Anna Masiak, i dr.
Izdano: (2016-03-01)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
od: Daniel Gutierrez, MD, i dr.
Izdano: (2022-04-01)

Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1.
od: Liew, C, i dr.
Izdano: (2006)

PU.1 and Haematopoietic Cell Fate: Dosage Matters
od: Ka Sin Mak, i dr.
Izdano: (2011-01-01)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
od: Spyridon Megremis, i dr.
Izdano: (2021-03-01)

Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesis
od: Rossmann, Marlies P, i dr.
Izdano: (2021)

GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.
od: Elsa P Amanatiadou, i dr.
Izdano: (2015-01-01)

Inferring structural properties of protein-DNA binding using high-throughput sequencing. The paradigm of GATA1, KLF1 and their complexes GATA1/FOG1 and GATA1/KLF1. Insights into the transcriptional regulation of the erythroid cell lineage.
od: Oikonomopoulos, S
Izdano: (2014)

Amyopathic anti‐TIF1‐γ antibody‐positive dermatomyositis in a young man
od: Nicolas Kluger
Izdano: (2024-07-01)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
od: Upasana Agrawal MD, i dr.
Izdano: (2024-06-01)

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
od: B. Palterer, i dr.
Izdano: (2017-08-01)

Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.
od: Geoffroy Andrieux, i dr.
Izdano: (2012-01-01)

Correction: Inactivation of TIF1γ Cooperates with Kras to Induce Cystic Tumors of the Pancreas.
od: David F. Vincent, i dr.
Izdano: (2009-08-01)

Anti‐TIF‐1γ dermatomyositis: Erythematous eruption with weakness and normal creatine kinase
od: Lucy Mackie, i dr.
Izdano: (2024-06-01)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
od: Chih-Feng Wu, i dr.
Izdano: (2023-09-01)

Association of Mutation and Methylation in the Promoter Region of TIF1γ  with Non-small Cell Lung Cancer
od: Longqiang WANG, i dr.
Izdano: (2013-05-01)

Correction: Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
Izdano: (2009-08-01)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
od: Natsuo Tomita, MD, PhD, i dr.
Izdano: (2021-07-01)

Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
od: Bakri, Y, i dr.
Izdano: (2005)

PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
od: Takuya Yashiro, i dr.
Izdano: (2015-01-01)

Lineage-specific combinatorial action of enhancers regulates mouse erythroid Gata1 expression.
od: Drissen, R, i dr.
Izdano: (2010)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
od: Ryosuke Imai, i dr.
Izdano: (2021-04-01)

PTEN regulates hematopoietic lineage plasticity via PU.1-dependent chromatin accessibility
od: Zihan Xu, i dr.
Izdano: (2023-08-01)

Association Between Anti‐TIF1‐γ Antibody and Triple‐Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report
od: Fan Zhang, i dr.
Izdano: (2025-02-01)

A Case of Paraneoplastic Anti-TIF1-γ Antibody-Positive Dermatomyositis Presenting with Generalized Edema and Associated with Aortic Aneurysm
od: Raven Bennett, i dr.
Izdano: (2023-10-01)

Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice
od: Anaís Mariscal, i dr.
Izdano: (2021-02-01)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
od: Joanna E. Parkes, i dr.
Izdano: (2018-06-01)

The TIF1β-HP1 System Maintains Transcriptional Integrity of Hematopoietic Stem Cells
od: Satoru Miyagi, i dr.
Izdano: (2014-02-01)

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
od: Xinhui Zhao, i dr.
Izdano: (2022-09-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
od: Jason Kieffer, MD, i dr.
Izdano: (2024-03-01)

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
od: Gering, M, i dr.
Izdano: (2003)

Case Report: IVIG causing bilateral papilledema and increased intracranial hypertension in patients with anti-TIF-1γ antibody-positive JDM
od: Sarah Baluta, i dr.
Izdano: (2024-11-01)

A Case Report of Anti-TIF1-γAntibody-Positive Dermatomyositis Concomitant with Small Cell Neuroendocrine Carcinoma of the Urinary Bladder
od: Hiroyuki Hounoki, i dr.
Izdano: (2023-01-01)

Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
od: Lijuan Zhao, i dr.
Izdano: (2022-02-01)